These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 20007676)
61. Mineral and bone metabolism in dialysis: towards unified patient care? Pelletier S; Fouque D Nephrol Dial Transplant; 2011 Jan; 26(1):7-9. PubMed ID: 21106773 [No Abstract] [Full Text] [Related]
62. [Water and salt metabolism in chronic uremigenic nephropathies]. Mioni G; Cristinelli L; Messa PG; Montanaro D G Clin Med; 1980 May; 61(5):332-41. PubMed ID: 7450354 [No Abstract] [Full Text] [Related]
63. Second chances in mineral metabolism. Wolf M Clin J Am Soc Nephrol; 2010 Jan; 5(1):1-3. PubMed ID: 20007676 [No Abstract] [Full Text] [Related]
64. FGF23: a key player in mineral and bone disorder in CKD. Komaba H; Fukagawa M Nefrologia; 2009; 29(5):392-6. PubMed ID: 19820750 [TBL] [Abstract][Full Text] [Related]
66. With or without the kidney: the role of FGF23 in CKD. Fukagawa M; Kazama JJ Nephrol Dial Transplant; 2005 Jul; 20(7):1295-8. PubMed ID: 15840677 [No Abstract] [Full Text] [Related]
67. Lipoprotein metabolism and lipid management in chronic kidney disease. Kwan BC; Kronenberg F; Beddhu S; Cheung AK J Am Soc Nephrol; 2007 Apr; 18(4):1246-61. PubMed ID: 17360943 [No Abstract] [Full Text] [Related]
68. The role of fibroblast growth factor 23 in renal disease. Jonsson KB Nephrol Dial Transplant; 2005 Mar; 20(3):479-82. PubMed ID: 15735238 [No Abstract] [Full Text] [Related]
69. [Cardiovascular disease in patients with 4 and 5 stage chronic kidney disease. Patient in chronic dialysis]. Goicoechea MA Nefrologia; 2004; 24 Suppl(6):142-60, 187-235. PubMed ID: 15696904 [No Abstract] [Full Text] [Related]
70. [Antihypertensive therapy in patients with 4 and 5 stage chronic kidney disease undergoing periodic dialysis]. Goicoechea MA Nefrologia; 2004; 24 Suppl(6):161-71, 187-235. PubMed ID: 15696905 [No Abstract] [Full Text] [Related]
71. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients]. Inaguma D; Tatematsu M Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827 [TBL] [Abstract][Full Text] [Related]
72. How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis? Wyne KL; Fishbane S; Block GA; Warburton K; Berns JS; Neu AM; Warady BA Semin Dial; 2006; 19(1):8-24. PubMed ID: 16423174 [No Abstract] [Full Text] [Related]